Characterization of a Panel of Monoclonal Antibodies to Human Coagulation Factor XI and Detection of Factor XI in Hep G2 Cell Conditioned Medium

Y Ohkubo; D P O’Brien; T Kanehiro; H Fukui; E G D Tuddenham

doi:10.1055/s-0038-1645058

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1990; 63(03): 417-423
DOI: 10.1055/s-0038-1645058

Original Article

Schattauer GmbH Stuttgart

Characterization of a Panel of Monoclonal Antibodies to Human Coagulation Factor XI and Detection of Factor XI in Hep G2 Cell Conditioned Medium

Autor*innen

Y Ohkubo

The Haemostasis Research Group, Clinical Research Centre, Harrow, Middx., U. K.
D P O’Brien

The Haemostasis Research Group, Clinical Research Centre, Harrow, Middx., U. K.
T Kanehiro

^*The Paediatric Department, Nara Medical College, Nara, Japan
H Fukui

^*The Paediatric Department, Nara Medical College, Nara, Japan
E G D Tuddenham

The Haemostasis Research Group, Clinical Research Centre, Harrow, Middx., U. K.

Abstract

als PDF herunterladen

Summary

We have produced a panel of ten monoclonal antibodies specific to coagulation factor XI. Western blot analysis demonstrates that 9 of these antibodies react with the heavy chain of factor XI and one with the light chain. Seven of these antibodies inhibit factor XI and factor XIa activity.

We have used immobilised monoclonal antibody for the production of factor XI deficient plasma and to purify factor XI to homogeneity with high yield in a simple two-step procedure. These monoclonal antibodies were used to develop highly sensitive immunoassays capable of detecting less than 0.01 u factor XI antigen ml⁻¹. A strong correlation was found between antigen and activity levels in 11 patients with hereditary deficiency indicating that none was cross-reacting material positive. Cultured Hep G2 cells were found to synthesize small amounts of factor XI antigen and this could also be detected by functional assay and by western blot analysis.

PDF (515 kb)

Referenzen

References
1 Bouma BN, Griffin JH. Human blood coagulation factor XI. J Biol Chem 1977; 252: 6432-7
2 Kurachi K, Davie EW. Activation of human factor XI (plasma thromboplastin antecedent by factor XIla (activated Hageman factor). Biochemistry 1977; 16: 5831-9
3 Mannhalter C, Schiffman S, Jacobs A. Trypsin activation of human factor XI. J Biol Chem 1980; 255: 2667-9
4 van der Graaf F, Greengard JS, Bouma BN, Kerbiriou DM, Griffin JH. Isolation and functional characterization of active light chain of activated human blood coagulation factor XI. J Biol Chem 1983; 258: 9669-75
5 Sinha D, Seaman FS, Walsh PN. Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX. Biochemistry 1987; 26: 3768-75
6 Goodall AH, Kemble G, O’Brien DP, Rawlings E, Rotblat F, Russel GC, Janossy G, Tuddenham EG D. Preparation of factor IX deficient human plasma by immunoaffinity chromatography using a monoclonal antibody. Blood 1982; 59: 664-70
7 Meyer D, Zimmerman TS, Obert B, Edgington TS. Hybridoma antibodies to human von Willebrand factor. I. Characterization of twenty-seven subclones. Br J Haematol 1984; 57: 597-608
8 Yoshioka A, Giddings JC, Thomas JE, Fujimura Y, Bloom AL. Immunoassays of factor IX antigen using monoclonal antibodies. Br J Haematol 1985; 59: 265-75
9 Broze GJ, Hickman S, Miletich JP. Monoclonal anti-human factor VII antibodies. J Clin Invest 1985; 76: 937-46
10 Sinha D, Koshy A, Seaman FS, Walsh PN. Functional characterization of human blood coagulation factor XIa using hybridoma antibodies. J Biol Chem 1985; 260: 10714-9
11 Okubo Y, Shima M, Sugimoto M, Kanehiro T, Oku K, Tanaka I, Yoshioka A, Fukui H. The production and characterization of four monoclonal antibodies to human factor X. Nara Med Assoc 1987; 38: 20-8
12 Mishell BB, Shigi SM. Selected Methods in Cellular Immunology. W. H. Freeman; San Francisco, CA: 1980
13 Ey PL, Prowse SL, Jenkin CR. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using Protein A-Sepha-rose. Immunochemistry 1978; 15: 429-36
14 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc Natl Acad Sci; USA: 1979. 76 4350-4
15 Knowles B, Howe C, Aden D. Human hepatocellular carcinoma cell lines secrete the major plasma protein and hepatitis B surface antigen. Science 1980; 209: 497-9
16 Saito H, Goldsmith GH. Plasma thromboplastin antecedent (PTA, Factor XI): A specific and sensitive radioimmunoassay. Blood 1977; 50: 377-85
17 Scott CF, Sinha D, Seaman FS, Walsh PN, Colman RW. Amidolytic assay of human factor XI in plasma: Comparison with a coagulant assay and a new rapid radioimmunoassay. Blood 1984; 63: 42-50
18 Saito H, Ratnoff OD, Bouma BN, Seligsohn V. Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: A study of 125 patients of several ethnic backgrounds. J Lab Clin Med 1985; 106: 718-22
19 Mannhalter PH, Deutsch E. Identification of a defective factor XI cross-reacting material in a factor XI deficient patient. Blood 1987; 70: 31-7
20 Asakai R, Davie EW, Chung DW. Organization of the gene for human factor XI. Biochemistry 1987; 26: 7221-8
21 Fujikawa K, Chung DW, Hendrickson LE, Davie EW. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with Plasma Prekallikrein. Biochemistry 1986; 25: 2417-24
22 Aden DP, Fogel A, Plotkin S, Damjanou I, Knowles BB. Controlled synthesis of HBs Ag in a differentiated human liver carcinoma-derived cell line. Nature 1979; 282: 615-6
23 Ou J-H, Kutter WJ. Hybrid hepatitis B virus - host transcripts in a human hepatoma cell. Proc Natl Acad Sci 1985; 82: 83-7
24 Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor XI coagulant activity and factor XI antigen in 25 factor XI deficient kindreds. Blood 1985; 65: 718-24